China Biopharmaceuticals Holdings Completes All Clinical Trials Of Desloratadine For Hay Fever
Wed, 22 Nov 2006 08:00 AM EST
... China Biopharmaceuticals Holdings, Inc. (OTC Bulletin Board: CHBP), a leading Chinese pharmaceutical company focused on the development, manufacturing and marketing of innovative drugs in China, today announced the completion of all required clinical trials for Desloratadine tablets for seasonal allergic rhinitis, also known as hay fever. [click link for full article] ...

Not Signed In -


